Mallinckrodt announced a $1.6 billion opioid settlement that will put the company’s generics business into bankruptcy.
Cambridge, Massachusetts-based Moderna shipped the company’s first batch of mRNA-1273, a vaccine against the coronavirus, for a planned Phase I clinical trial in the U.S.
Allecra Therapeutics indicated the company’s Exblifep (cefepime-enmetazobactam) hit pre-specified primary endpoints in the Phase III ALLIUM clinical trial in complicated urinary tract infections, including acute pyelonephritis.
Multiple biopharmaceutical companies are developing assets to treat migraines.
Bicycle Therapeutics announced a strategic collaboration agreement with Genentech, a member of the Roche Group, to discover, develop and commercialize novel Bicycle-based immuno-oncology therapies.
Novartis launched an external review into the safety of the company’s blindness medicine Beovu after the American Society of Retinal Specialists (ASRS) raised concerns.
